Emergency Medicine PHARMacotherapy research NETwork 🚨 Pushing the EM PharmD profession forward through high quality, collaborative research 📄
Joined February 2021
- Tweets73
- Following828
- Followers1.5K
- Likes78
Out in @JACCPJournal : A Cross-Sectional Survey of Knowledge, Confidence, and Decision-Making in Acute Stroke in the Era of Anti-Amyloid Therapies
Among 204 EM clinicians:
💡 Knowledge of AATs was low
🚨 Confidence in recognizing & managing ARIA limited
accpjournals.onlinelibrary.w…
EMPHARM-NET retweeted
📣 Check out the latest @EMPHARM_NET study of 362 adults with TBI or sICH at 11 US EDs who received sugammadex
📈 A positive response (⬆️GCS ≥1) was seen in 54% & associated with a new analgesia, sedation & non-significant⬆️neurosurgical procedures
👉sciencedirect.com/science/ar…
📣 Check out the latest @EMPHARM_NET study of 362 adults with TBI or sICH at 11 US EDs who received sugammadex
📈 A positive response (⬆️GCS ≥1) was seen in 54% & associated with a new analgesia, sedation & non-significant⬆️neurosurgical procedures
👉sciencedirect.com/science/ar…
📢Check out our new publication on forming & maintaining a research network: Emergency Medicine PHARMacotherapy research NETwork (EMPHARM-NET), established to unify investigators, foster mentorship, & advance high-quality EM research authors.elsevier.com/a/1mlSz…
📣 Calling all EM clinicians: please take our IRB-approved anonymous survey examining awareness & experience with anti-amyloid therapies
Survey link: redcap.link/anti-amyloid_the…
We aim to reach a broad EM audience to characterize awareness of AATs & compile innovative strategies
EMPHARM-NET retweeted
@bfaine1 & I penned an editorial called Pharmacists on the Front Lines: Advances in Emergency Medicine Pharmacy Practice on the history and advancement of EM pharmacy culminating in this EM themed issue🚨
academic.oup.com/ajhp/articl…
EMPHARM-NET retweeted
Excited to share the Emergency Medicine themed issue of @ASHPOfficial @AJHPOfficial that I guested edited w/ @bfaine1.
20 ( ‼️ ) papers & >50 EM pharmacists - this is a testament to how talented and diverse our EM pharmacy community is!
Read here 👉academic.oup.com/ajhp/issue/…
EMPHARM-NET retweeted
💡 Need one more reason to love your friendly EM pharmacist? Check out this @EMPHARM_NET SR/MA:
⏰ EMP presence was associated with reduced mean DTN time by 14.6 minutes (95 % CI -18.1, −11.1 min)
Time for @American_Stroke @American_Heart to take notice?
Just published in #AJEM! 📄
#PhAST1 is the first systematic review & meta-analysis quantifying the impact of #EMPharmD on stroke #doortoneedle times 🧠🚑
📉 Faster treatment
🤝 More interprofessionalism
🏥 Justification for expanding #EMPharmD services
doi.org/10.1016/j.ajem.2025.…
Check out our new SR/MA on the benefits of an EM pharmacist on thrombolytic DTN time in acute ischemic stroke 🧠
Just published in #AJEM! 📄
#PhAST1 is the first systematic review & meta-analysis quantifying the impact of #EMPharmD on stroke #doortoneedle times 🧠🚑
📉 Faster treatment
🤝 More interprofessionalism
🏥 Justification for expanding #EMPharmD services
doi.org/10.1016/j.ajem.2025.…
🔥 New study HBV s/p sexual assault:
🏥 1010 patients, 10 @EMPHARM_NET EDs
💉 62.7 % with no/unknown vaccine history - only 5.8% received HBV vaccine
🧪 HBV serology testing 63.6%
🦠 8 patients received HBIG
🚨 Room for improvement in HBV care
Free link: sciencedirect.com/science/ar…
🔥 Off the Press: Risk factors for enterococcal UTI in ED patients (n=1836, 5% Enterococcus)
🧪 Combination of positive leukocyte esterase (LE+) and negative nitrite (NI−) significantly associated w/ Enterococcus UTI (aOR 7.1, 95 % CI 3.73–13.5)
sciencedirect.com/science/ar…
EMPHARM-NET retweeted
📣Have you heard of antiamyloid therapies for AD? They cause ADEs called ARIAs that are non-specific, typically require MRI & can mimic stroke
⛔ Concomitant thrombolytics/anticoagulants are contraindicated
Learn more in our JAMA IM Clinical Insight👉 jamanetwork.com/journals/jam…
EMPHARM-NET retweeted
So excited to announce that @SAEM_AEMP is officially an @SAEMonline Academy! Thanks so everyone who worked so hard to get us to this point & continue to promote our mission of advancing EM pharmacy practice! So grateful to work with all of you! @LRayRx @EmergPharm
EMPHARM-NET retweeted
🎉 Big news from #SAEM25 -- AEMP is officially transitioning to an academy within SAEM!!
🥳 We are so excited for the opportunities this will offer us!
🥂 Thankful for all our members & the group of EM pharmacist leaders who made this possible!!
#AEMPlify #AEMP25 @SAEMonline
Hot off the press: 🔥
New EMPHARM-NET study on desmopressin administration in antiplatelet-related ICH. Link here 👇
🔥New @EMPHARM_NET DONT EXPAND Study:
💊Propensity-matched, 11 EDs: desmopressin (n=35) vs. controls (n=140)
😷Desmo patients had higher baseline ICH volumes
🧠No difference in good or excellent hemostatic efficacy assessed via hematoma volume measures
sciencedirect.com/science/ar…
📣Check out our latest publication📣
The 2024 EM Pharmacotherapy literature review is here. Check out the most impactful studies of the last year 👇
🚨 Just published in AJEM from @EMPHARM_NET:
CuratED: The 2024 Emergency Medicine Drug Lit Review
🔥 11 RCTs
📜 10 guidelines
🔍 7 meta-analyses
💊 DAPT & stroke, steroids & CAP, TXA & ICH, Andexxa & more
Stay EM Pharm sharp👇
🔗 doi.org/10.1016/j.ajem.2025.…
#FOAMed #MedED
Our COPY-ED study was highlighted in NEJM Journal Watch: jwatch.org/na58569/2025/03/1…
@bfaine1 @ThePeoplesRuben @giles_slocum @DEZ_EM_Pharm @gavin_howington @AM_EM_PharmD @annezepeski @MeganARech
🔥Hot off the press: @EMPHARM_NET COPY-ED Study:
💊 Oral cephalosporins (n=647) vs IDSA guideline concordant FQ or TMP-SMX (n=204) for pyelonephritis in patients discharged from the ED
🙅♀️No difference in 14 d treatment failure
@jlkoehl @bfaine1
sciencedirect.com/science/ar…